Can we get antibiotics right for kids on ECMO?

NCT ID NCT06426836

Recruiting now Knowledge-focused Sponsor: University Hospital, Ghent Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how antibiotics behave in the bodies of critically ill newborns, infants, and children who are on a heart-lung machine called ECMO. Researchers want to find out if current doses are high enough to fight infections without causing harm. The goal is to improve dosing guidelines for these vulnerable patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMIKACIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMIKACIN AMOXICILLIN-CLAVULANATE CEFAZOLIN CIPROFLOXACIN MEROPENEM PHARMACOKINETICS PIPERACILLIN-TAZOBACTAM TEICOPLANIN VANCOMYCIN

Contacts and locations

Locations

Queen Fabiola Children's University Hospital
RECRUITING

Brussels, Brussels Capital, 1020, Belgium
Universitair hospital
RECRUITING

Leuven, 3000, Belgium
University Hospital
RECRUITING

Ghent, 9000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.